SCHEMBL30508796

SCHEMBL30508796

Cc1cc(C(=O)N(C)C)c(N)nn1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 2/20 0.43
PIK3C3 Q8NEB9 1/20 0.38
MAP4K1 Q92918 7/20 0.36
ALDH1A1 P00352 2/20 0.35
SPR P35270 1/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDM4E B2RXH2 1/20 0.33
EIF2S1 P05198 1/20 0.33
EIF2AK3 Q9NZJ5 1/20 0.33
LRRK2 Q5S007 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ATR Q13535 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25319546 1.00 OPRK1 (0.43) OPRK1PIK3C3MAP4K1ALDH1A1SPR
SCHEMBL3560530 0.80 ALDH1A1 (0.41) PIK3C3MAP4K1ALDH1A1MEN1KMT2A
SCHEMBL30508857 0.78 OPRK1 (0.43) OPRK1PIK3C3ALDH1A1SPRMEN1
SCHEMBL25319161 0.78 OPRK1 (0.43) OPRK1PIK3C3ALDH1A1SPRMEN1
SCHEMBL24576946 0.73 PIK3C3 (0.49) PIK3C3MAP4K1MEN1KMT2AEIF2S1
SCHEMBL13771341 0.71 KDM4E (0.51) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL857401 0.68 PIK3C3 (0.48) OPRK1PIK3C3MAP4K1ALDH1A1KMT2A
SCHEMBL25316948 0.66 SMN1; SMN2 (0.38) OPRK1ALDH1A1MEN1KMT2AHPGD
SCHEMBL30508876 0.66 SMN1; SMN2 (0.38) OPRK1ALDH1A1MEN1KMT2AHPGD
SCHEMBL24609146 0.66 PIK3C3 (0.46) PIK3C3MAP4K1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746965-A1 BENZIMIDAZOLES AS SIK-ACTIVITY MODULATORS F. Hoffmann-La Roche AG (CH) 2026-05-27 EP disclosed
EP-4642535-A1 BENZIMIDAZOLE DERIVATIVES USEFUL AS SIK MODULATORS F. Hoffmann-La Roche AG (CH) 2025-11-05 EP disclosed
EP-4642773-A1 NEW BENZIMIDAZOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2025-11-05 EP disclosed
EP-4547662-A1 IMIDAZO[4,5-B]PYRIDINE AND PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS SIK MODULATORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS F. Hoffmann-La Roche AG (CH) 2025-05-07 EP disclosed
WO-2025017041-A1 BENZIMIDAZOLES AS SIK-ACTIVITY MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2025-01-23 WO disclosed
EP-4466258-A1 NEW BENZIMIDAZOLE PYRIDINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2024-11-27 EP disclosed
WO-2024141443-A1 BENZIMIDAZOLE DERIVATIVES USEFUL AS SIK MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2024-07-04 WO disclosed
WO-2024141444-A1 NEW BENZIMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2024-07-04 WO disclosed
WO-2024003208-A1 IMIDAZO[4,5-B]PYRIDINE AND PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS SIK MODULATORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS F. HOFFMANN-LA ROCHE AG (CH) 2024-01-04 WO disclosed
WO-2023139085-A1 NEW BENZIMIDAZOLE PYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2023-07-27 WO disclosed